Effect of pistachio consumption on the modulation of urinary gut microbiota-related metabolites in prediabetic subjects

Journal of Nutritional Biochemistry

Volumn 45, Issue , 2017, Pages 48-53

  Hernández Alonso, Pablo ^a,b   Cañueto, Daniel ^c,d   Giardina, Simona ^a   Salas Salvadó, Jordi ^a,b   Cañellas, Nicolau ^c,d   Correig, Xavier ^c,d   Bulló, Mònica ^a,b  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Insulin resistance; Metabolomics; Microbiota; Nuts; Pistachios; Prediabetes

Indexed keywords

4 CRESOL SULFATE; ACONITIC ACID; CREATININE; CRESOL; DIMETHYLAMINE; GLUCOSE; HIPPURIC ACID; N METHYL TRANS 4 HYDROXY LEVO PROLINE; TRICARBOXYLIC ACID; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; 4-CRESOL; HIPPURIC ACID DERIVATIVE; METHYLAMINE; TRIMETHYLOXAMINE;

ADULT; ARTICLE; CARBOHYDRATE INTAKE; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSSOVER PROCEDURE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTESTINE FLORA; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PISTACHIO; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; CHEMISTRY; DIET; DIET THERAPY; PHYSIOLOGY; PISTACIA; PRINCIPAL COMPONENT ANALYSIS; URINE;

CRESOLS; DIET; DIMETHYLAMINES; FEMALE; GASTROINTESTINAL MICROBIOME; HIPPURATES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHYLAMINES; MIDDLE AGED; PISTACIA; PREDIABETIC STATE; PRINCIPAL COMPONENT ANALYSIS; URINE;

EID: 85017589677     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2017.04.002     Document Type: Article

References (40)

1. [1] Ros, E., Health benefits of nut consumption. Forum Nutr 2 (2010), 652–682.
2. [2] Tan, S.Y., Dhillon, J., Mattes, R.D., A review of the effects of nuts on appetite, food intake, metabolism, and body weight. Am J Clin Nutr 100 (2014), 412S–422S [Suppl].
3. [3] Lamuela-Raventos, R.M., St Onge, M.-P., Prebiotic nut compounds and human microbiota. Crit Rev Food Sci Nutr, 2016 [0].
4. [4] Kau, A.L., Ahern, P.P., Griffin, N.W., Goodman, A.L., Gordon, J.I., Human nutrition, the gut microbiome and the immune system. Nature 474 (2011), 327–336.
5. [5] Munukka, E., Wiklund, P., Pekkala, S., Völgyi, E., Xu, L., Cheng, S., et al. Women with and without metabolic disorder differ in their gut microbiota composition. Obesity, 2012, 1082–1087.
6. [6] Howitt, M.R., Garrett, W.S., A complex microworld in the gut: gut microbiota and cardiovascular disease connectivity. Nat Med 18 (2012), 1188–1189.
7. [7] Zhang, C., Li, S., Yang, L., Huang, P., Li, W., Wang, S., et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun, 4, 2013, 2163.
8. [8] Ukhanova, M., Wang, X., Baer, D.J., Novotny, J.A., Fredborg, M., Mai, V., Effects of almond and pistachio consumption on gut microbiota composition in a randomised cross-over human feeding study. Br J Nutr 111 (2014), 2146–2152.
9. [9] Liu, Z., Lin, X., Huang, G., Zhang, W., Rao, P., Ni, L., Prebiotic effects of almonds and almond skins on intestinal microbiota in healthy adult humans. Anaerobe 26 (2014), 1–6.
10. [10] O'Keefe, S.J.D., Li, J.V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun, 6, 2015, 6342 [Nature Publishing Group].
11. [11] Hernández-Alonso, P., Salas-Salvadó, J., Baldrich-Mora, M., Juanola-Falgarona, M., Bulló, M., Beneficial effect of pistachio consumption on glucose metabolism, insulin resistance, inflammation, and related metabolic risk markers: a randomized clinical trial. Diabetes Care 37 (2014), 3098–3105.
12. [12] Hernández-Alonso, P., Salas-Salvadó, J., Baldrich-Mora, M., Mallol, R., Correig, X., Bulló, M., Effect of pistachio consumption on plasma lipoprotein subclasses in pre-diabetic subjects. Nutr Metab Cardiovasc Dis 25 (2015), 396–402.
13. [13] Gómez, J., Brezmes, J., Mallol, R., Rodríguez, M.A., Vinaixa, M., Salek, R.M., et al. Dolphin: a tool for automatic targeted metabolite profiling using 1D and 2D (1)H-NMR data. Anal Bioanal Chem 406 (2014), 7967–7976.
14. [14] Gómez, J., Vinaixa, M., Rodríguez, M.A., Salek, R.M., Correig, X., Cañellas, N., Dolphin 1D: improving automation of targeted metabolomics in multi-matrix datasets of1H-NMR spectra. Adv Intell Syst Comput, 2015, 59–67.
15. [15] Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., et al. HMDB 3.0-the human metabolome Database in 2013. Nucleic Acids Res, 41, 2013.
16. [16] Ulrich, E.L., Akutsu, H., Doreleijers, J.F., Harano, Y., Ioannidis, Y.E., Lin, J., et al. BioMagResBank. Nucleic Acids Res 36 (2008), D402–D408.
17. [17] Vázquez-Fresno, R., Llorach, R., Urpi-Sarda, M., Lupianez-Barbero, A., Estruch, R., Corella, D., et al. Metabolomic pattern analysis after mediterranean diet intervention in a nondiabetic population: a 1- and 3-year follow-up in the PREDIMED study. J Proteome Res 14 (2015), 531–540 [American Chemical Society].
18. [18] Mayneris-Perxachs, J., Lima, A.A.M., Guerrant, R.L., Leite, Á.M., Moura, A.F., Lima, N.L., et al. Urinary N-methylnicotinamide and β-aminoisobutyric acid predict catch-up growth in undernourished Brazilian children. Sci Rep, 6, 2016, 19780.
19. [19] Lê Cao, K.A., González, I., Déjean, S., IntegrOmics: an R package to unravel relationships between two omics datasets. Bioinformatics 25 (2009), 2855–2856.
20. [20] Van Velzen, E.J.J., Westerhuis, J.A., Van Duynhoven, J.P.M., Van Dorsten, F.A., Hoefsloot, H.C.J., Jacobs, D.M., et al. Multilevel data analysis of a crossover designed human nutritional intervention study. J Proteome Res 7 (2008), 4483–4491.
21. [21] Sciubba, F., Capuani, G., Di Cocco, M.E., Avanzato, D., Delfini, M., Nuclear magnetic resonance analysis of water soluble metabolites allows the geographic discrimination of pistachios (Pistacia vera). Food Res Int 62 (2014), 66–73.
22. [22] Madrid-Gambin, F., Garcia-Aloy, M., Vázquez-Fresno, R., Vegas-Lozano, E., de Villa Jubany, M.C.R., Misawa, K., et al. Impact of chlorogenic acids from coffee on urine metabolome in healthy human subjects. Food Res Int, 2016.
23. [23] Nieman, D.C., Scherr, J., Luo, B., Meaney, M.P., Dréau, D., Sha, W., et al. Influence of pistachios on performance and exercise-induced inflammation, oxidative stress, immune dysfunction, and metabolite shifts in cyclists: a randomized, crossover trial. PLoS One, 9, 2014.
24. [24] Salek, R.M., Maguire, M.L., Bentley, E., Rubtsov, D.V., Hough, T., Cheeseman, M., et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 29 (2007), 99–108.
25. [25] Pelantová, H., Bugáňová, M., Holubová, M., Šedivá, B., Zemenová, J., Sýkora, D., et al. Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination. Mol Cell Endocrinol, 2016.
26. [26] Guan, M., Xie, L., Diao, C., Wang, N., Hu, W., Zheng, Y., et al. Systemic perturbations of key metabolites in diabetic rats during the evolution of diabetes studied by urine metabonomics. PLoS One, 8, 2013.
27. [27] Lees, H.J., Swann, J.R., Wilson, I.D., Nicholson, J.K., Holmes, E., Hippurate: the natural history of a mammalian-microbial cometabolite. J Proteome Res 12 (2013), 1527–1546.
28. [28] Van Doorn, M., Vogels, J., Tas, A., Van Hoogdalem, E.J., Burggraaf, J., Cohen, A., et al. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol 63 (2007), 562–574.
29. [29] Dawson, L.F., Donahue, E.H., Cartman, S.T., Barton, R.H., Bundy, J., McNerney, R., et al. The analysis of para-cresol production and tolerance in Clostridium Difficile 027 and 012 strains. BMC Microbiol, 11, 2011, 86.
30. [30] Roediger, W.E., Babidge, W., Human colonocyte detoxification. Gut 41 (1997), 731–734.
31. [31] Kochhar, S., Martin, F.-P., (eds.) Metabonomics and gut microbiota in nutrition and disease [internet], 2015, Springer London, London.
32. [32] Meijers, B.K.I., Van kerckhoven, S., Verbeke, K., Dehaen, W., Vanrenterghem, Y., Hoylaerts, M.F., et al. The uremic retention solute p-Cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 54 (2009), 891–901.
33. [33] Vanholder, R., Schepers, E., Pletinck, A., Nagler, E.V., Glorieux, G., The uremic toxicity of Indoxyl sulfate and p-Cresyl sulfate: a systematic review. J Am Soc Nephrol, 2014, 1–11.
34. [34] Patel, K.P., Luo, F.J.G., Plummer, N.S., Hostetter, T.H., Meyer, T.W., The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol 7 (2012), 982–988.
35. [35] Stephen, A.M., Wiggins, H.S., Cummings, J.H., Effect of changing transit time on colonic microbial metabolism in man. Gut 28 (1987), 601–609.
36. [36] Moco, S., Ross, A.B., Can we use metabolomics to understand changes to gut microbiota populations and function?. A nutritional perspective, 2015, 83–108.
37. [37] Shih, D.M., Wang, Z., Lee, R., Meng, Y., Che, N., Charugundla, S., et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J Lipid Res 56 (2015), 22–37.
38. [38] Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
39. [39] Li, M., Wang, B., Zhang, M., Rantalainen, M., Wang, S., Zhou, H., et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci 105 (2008), 2117–2122.
40. [40] Dumas, M.E., Barton, R.H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin resistant mice. Proc Natl Acad Sci 103 (2006), 12511–12516.